跳至主要内容
临床试验/JPRN-UMIN000024753
JPRN-UMIN000024753已完成2 期

A clinical trial of efficacy and safety of sodium phenylbutyrate in progressive familial intrahepatic cholestasis type 2 - A clinical trial of efficacy and safety of sodium phenylbutyrate in progressive familial intrahepatic cholestasis type 2

Japan Agency for Medical Research and Development0 个研究点目标入组 6 人开始时间: 2016年12月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Those who participated in another study within 3 months 2)Those who have hypersensitivity with phenylbutylate and/or its metabolite 3)Those who received liver transplantation 4)Those who received biliary diversion 5)Those who are pregnant or hoping pregnancy 6)Those who cannot accept to practice contraception 7)Those with congestive heart failure 8)Those with renal dysfunction 9)Those with nonsense or frameshift mutation, or exon deletion in both ABCB11 alleles 10) Those with liver cirrhosis

研究者

相似试验

A clinical trial of efficacy and safety of sodium... | 临床试验